SUNDAY, NOVEMBER 02 Poster C. Nsanzabana Young Investigators Award: Artemether-lumefantrine efficacy: – Marriott - Preservation Hall potential for further dose optimisation Studio 8 - 10:00am-03:00pm Presenter: Christian Nsanzabana MONDAY, NOVEMBER 03 Oral Pres. C. Nsanzabana Presentation: Artemether-lumefantrine efficacy: potential for – Sheraton Grand Ballroom D further dose optimization – Session 08 - 08:00am-09:45am Session: Malaria: Chemotherapy - Malaria Treatment Point/Counterpoint Debate: Primaquine Should Not Be Deployed Symposium without G6PD Testing Sheraton Grand Ballroom C – Speakers: Ric Price, Nick White, Kevin Baird, Francois Nosten, Satu Session 49 - 4 :00pm-5:45pm Ntshalintshali, Chaired by Bruno Moonen and Dennis Shanks Poster C. Woodrow Persistence of P. falciparum diagnostic antigens after treatment – Marriott - Grand Ballroom with artemisinins: association with parasite stage and mechanism of clearance Session 28 - 12:00 pm - 1:45pm TUESDAY, NOVEMBER 04 Symposium Symposium: Treating Malaria: Getting the Dose Sheraton Grand Ballroom E Speakers: Nick White, Ric Price, Joel Tarning, Jörg Möhrle and Anja – Session 78 - 10:15am-12:00pm Terlouw. Chaired by Nick White & Piero Olliaro WEDNESDAY, NOVEMBER 05 Symposium Symposium: Artemisinin-Resistant Malaria in a “Post-Marker” Sheraton Grand Ballroom C Latest Findings from in vitro, Genomic, Epidemiological and Clinical – Session 132 - 10:15am-12:00pm Studies Speakers: Nick White, Arjen Dondorp, Dominic Kwiatkowski and Didier Menard Late Breaker Pres. C. Woodrow Late breaker session: Defining the leading edge of P. falciparum – Sheraton–Mardi Gras Ballroom E artemisinin resistance in Myanmar Session 142 12:15pm 1:30pm Speaker: Charles Woodrow – –
SUNDAY, NOVEMBER 02 Poster – C. Nsanzabana Marriott - Preservation Hall Studio 8 - 10:00am-03:00pm Young Investigators Award: Artemether-lumefantrine efficacy: potential for further dose optimisation Presenter: Christian Nsanzabana MONDAY, NOVEMBER 03 Oral Pres. – C. Nsanzabana Sheraton – Grand Ballroom D Session 08 - 08:00am-09:45am Presentation: Artemether-lumefantrine efficacy: potential for further dose optimization Session: Malaria: Chemotherapy - Malaria Treatment Symposium Sheraton – Grand Ballroom C Session 49 - 4 :00pm-5:45pm Point/Counterpoint Debate: Primaquine Should Not Be Deployed without G6PD Testing Speakers: Ric Price, Nick White, Kevin Baird, Francois Nosten, Satu Ntshalintshali, Chaired by Bruno Moonen and Dennis Shanks Poster – C. Woodrow Marriott - Grand Ballroom Session 28 - 12:00 pm - 1:45pm Persistence of P. falciparum diagnostic antigens after treatment with artemisinins: association with parasite stage and mechanism of clearance TUESDAY, NOVEMBER 04 Symposium Sheraton – Grand Ballroom E Session 78 - 10:15am-12:00pm Symposium: Treating Malaria: Getting the Dose Speakers: Nick White, Ric Price, Joel Tarning, Jörg Möhrle and Anja Terlouw. Chaired by Nick White & Piero Olliaro WEDNESDAY, NOVEMBER 05 Symposium Sheraton – Grand Ballroom C Session 132 - 10:15am-12:00pm Symposium: Artemisinin-Resistant Malaria in a “Post-Marker” Latest Findings from in vitro, Genomic, Epidemiological and Clinical Studies Speakers: Nick White, Arjen Dondorp, Dominic Kwiatkowski and Didier Menard Late Breaker Pres. – C. Woodrow Sheraton–Mardi Gras Ballroom E Session 142 – 12:15pm – 1:30pm Late breaker session: Defining the leading edge of P. falciparum artemisinin resistance in Myanmar Speaker: Charles Woodrow
WWARN-partners-ASTMH-A5%20Flyer-Schedule-version-October-21-2014_0.docx